Skip to main content

Advertisement

SpringerLink
Log in

A telomerase regulation-related lncRNA signature predicts prognosis and immunotherapy response for gastric cancer

  • Research
  • Published:
Journal of Cancer Research and Clinical Oncology Aims and scope Submit manuscript

Abstract

Background

Telomeres are involved in the development and progression of gastric cancer (GC). However, the association of telomerase regulation-related lncRNAs with prognosis and immunotherapy responsiveness in gastric cancer is unclear.

Methods

This study systematically evaluated the relationship between lncRNAs co-expressed with 67 telomerase regulatory genes and gastric cancer prognosis. The risk scores of the samples were calculated based on telomerase regulation-related lncRNAs with prognostic value, and the samples were classified into high-/low-risk groups. The prognostic value of risk groups was then evaluated, a GC prognostic prediction model based on risk groups and clinical characteristics was established, and the prediction accuracy of the model was clarified by receiving operating characteristic (ROC) curves and calibration curves. Finally, the value of risk grouping in GC immunotherapy sensitivity was predicted by comparing MSI status and tumor mutation load between the high- and low-risk groups.

Results

We identified 13 lncRNAs with prognostic value co-expressed with telomerase regulatory genes and observed that the prognosis of the low-risk group was significantly better than that of the high-risk group. Meanwhile, a GC overall survival (OS) prediction model based on risk grouping and clinical characteristics was developed, and ROC curves and calibration curves confirmed the good predictive ability of the model. In addition, the low-risk group exhibited a higher tumor mutation load and MSI-H, suggesting a possible benefit of immunotherapy.

Conclusion

We found that telomerase regulation-related lncRNAs have prognostic value in GC patients and contribute to the exploration of more effective immunotherapeutic strategies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

Availability of supporting data

The TCGA database (https://portal.gdc.cancer.gov/) belongs to the public databases. The patients involved in the database obtained ethical approval. Users can download relevant data for free for research and publish relevant articles. Our study is based on open source data, so there are no ethical issues or other conflicts of interest.

References

  • Biondi A, Lirosi MC, D’Ugo D, Fico V, Ricci R, Santullo F et al (2015) Neo-adjuvant chemo(radio)therapy in gastric cancer: current status and future perspectives. World J Gastrointest Oncol 7(12):389–400

    Article  Google Scholar 

  • Cai H, Jing C, Chang X, Ding D, Han T, Yang J et al (2019) Mutational landscape of gastric cancer and clinical application of genomic profiling based on target next-generation sequencing. J Transl Med 17(1):189

    Article  Google Scholar 

  • Cristescu R, Mogg R, Ayers M, Albright A, Murphy E, Yearley J, et al. Pan-tumor genomic biomarkers for PD-1 checkpoint blockade-based immunotherapy. Science. 2018;362(6411).

  • Derrien T, Johnson R, Bussotti G, Tanzer A, Djebali S, Tilgner H et al (2012) The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression. Genome Res 22(9):1775–1789

    Article  CAS  Google Scholar 

  • Dong L, Liu D, Jing D, Xu H, Zhang C, Qi D et al (2022) LncRNA ARST is a novel prognostic and diagnostic biomarker for colorectal cancer. Cancer Manag Res 14:19–24

    Article  CAS  Google Scholar 

  • Du J, Zhu X, Xie C, Dai N, Gu Y, Zhu M et al (2015) Telomere length, genetic variants and gastric cancer risk in a Chinese population. Carcinogenesis 36(9):963–970

    Article  CAS  Google Scholar 

  • Ennour-Idrissi K, Maunsell E, Diorio C (2017) Telomere length and breast cancer prognosis: a systematic review. Cancer Epidemiol Biomark Prevent 26(1):3–10

    Article  CAS  Google Scholar 

  • Fu J, Li K, Zhang W, Wan C, Zhang J, Jiang P et al (2020) Large-scale public data reuse to model immunotherapy response and resistance. Genome Med 12(1):21

    Article  Google Scholar 

  • Gallicchio L, Gadalla SM, Murphy JD, Simonds NI (2018) The effect of cancer treatments on telomere length: a systematic review of the literature. J Natl Cancer Inst 110(10):1048–1058

    Article  Google Scholar 

  • Geeleher P, Cox N, Huang RS (2014) pRRophetic: an R package for prediction of clinical chemotherapeutic response from tumor gene expression levels. PLoS ONE 9(9):e107468

    Article  Google Scholar 

  • Giardini MA, Segatto M, da Silva MS, Nunes VS, Cano MI (2014) Telomere and telomerase biology. Prog Mol Biol Transl Sci 125:1–40

    Article  CAS  Google Scholar 

  • Gonzalez I, Munita R, Agirre E, Dittmer TA, Gysling K, Misteli T et al (2015) A lncRNA regulates alternative splicing via establishment of a splicing-specific chromatin signature. Nat Struct Mol Biol 22(5):370–376

    Article  CAS  Google Scholar 

  • Greider CW (1990) Telomeres, telomerase and senescence. BioEssays 12(8):363–369

    Article  CAS  Google Scholar 

  • Hanzelmann S, Castelo R, Guinney J (2013) GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinform 14:7

    Article  Google Scholar 

  • Hao J, Yuan B, Gou Y, Ma J, Huang X (2021) Prognostic value of lncRNA PVT1 for patients with gastric cancer: a meta-analysis. Dis Markers 2021:5595965

    Article  Google Scholar 

  • Hashimoto I, Oshima T. Claudins and Gastric Cancer: An Overview. Cancers. 2022;14(2).

  • He R, Man C, Huang J, He L, Wang X, Lang Y et al (2022) Identification of RNA methylation-related lncRNAs signature for predicting hot and cold tumors and prognosis in colon cancer. Front Genet 13:870945

    Article  CAS  Google Scholar 

  • Kim BK, Cheong JH, Im JY, Ban HS, Kim SK, Kang MJ, et al. PI3K/AKT/beta-catenin signaling regulates vestigial-like 1 which predicts poor prognosis and enhances malignant phenotype in gastric cancer. Cancers. 2019;11(12).

  • Kroupa M, Rachakonda SK, Liska V, Srinivas N, Urbanova M, Jiraskova K et al (2019) Relationship of telomere length in colorectal cancer patients with cancer phenotype and patient prognosis. Br J Cancer 121(4):344–350

    Article  CAS  Google Scholar 

  • Liu J, Lichtenberg T, Hoadley KA, Poisson LM, Lazar AJ, Cherniack AD et al (2018) An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics. Cell 173(2):400-16e11

    Article  CAS  Google Scholar 

  • Liu L, Bai X, Wang J, Tang XR, Wu DH, Du SS et al (2019) Combination of TMB and CNA stratifies prognostic and predictive responses to immunotherapy across metastatic cancer. Clin Cancer Res 25(24):7413–7423

    Article  CAS  Google Scholar 

  • Liu SJ, Dang HX, Lim DA, Feng FY, Maher CA (2021) Long noncoding RNAs in cancer metastasis. Nat Rev Cancer 21(7):446–460

    Article  CAS  Google Scholar 

  • Lu D, Luo P, Wang Q, Ye Y, Wang B (2017) lncRNA PVT1 in cancer: a review and meta-analysis. Clinica Chimica Acta Int J Clin Chem 474:1–7

    Article  CAS  Google Scholar 

  • Luo L, Li L, Liu L, Feng Z, Zeng Q, Shu X et al (2022) A Necroptosis-related lncRNA-based signature to predict prognosis and probe molecular characteristics of stomach adenocarcinoma. Front Genet 13:833928

    Article  CAS  Google Scholar 

  • Mao D, Xu R, Chen H, Chen X, Li D, Song S et al (2021) Cross-talk of focal adhesion-related gene defines prognosis and the immune microenvironment in gastric cancer. Front Cell Dev Biol 9:716461

    Article  Google Scholar 

  • Mayakonda A, Lin DC, Assenov Y, Plass C, Koeffler HP (2018) Maftools: efficient and comprehensive analysis of somatic variants in cancer. Genome Res 28(11):1747–1756

    Article  CAS  Google Scholar 

  • Mele M, Mattioli K, Mallard W, Shechner DM, Gerhardinger C, Rinn JL (2017) Chromatin environment, transcriptional regulation, and splicing distinguish lincRNAs and mRNAs. Genome Res 27(1):27–37

    Article  CAS  Google Scholar 

  • Ming J, Wang C (2022) N7-methylguanosine-related lncRNAs: integrated analysis associated with prognosis and progression in clear cell renal cell carcinoma. Front Genet 13:871899

    Article  CAS  Google Scholar 

  • Oh BK, Kim H, Park YN, Yoo JE, Choi J, Kim KS et al (2008) High telomerase activity and long telomeres in advanced hepatocellular carcinomas with poor prognosis. Lab Investig J Tech Methods Pathol 88(2):144–152

    Article  CAS  Google Scholar 

  • Park R, Da Silva LL, Saeed A (2021) Immunotherapy predictive molecular markers in advanced gastroesophageal cancer: MSI and beyond. Cancers. 13(7)

  • Patel TH, Cecchini M (2020) Targeted therapies in advanced gastric cancer. Curr Treat Options Oncol 21(9):70

    Article  Google Scholar 

  • Pitt JM, Marabelle A, Eggermont A, Soria JC, Kroemer G, Zitvogel L (2016) Targeting the tumor microenvironment: removing obstruction to anticancer immune responses and immunotherapy. Ann Oncol 27(8):1482–1492

    Article  CAS  Google Scholar 

  • Qi L, Zhang T, Yao Y, Zhuang J, Liu C, Liu R et al (2019) Identification of lncRNAs associated with lung squamous cell carcinoma prognosis in the competitive endogenous RNA network. PeerJ 7:e7727

    Article  Google Scholar 

  • Qing X, Xu W, Liu S, Chen Z, Ye C, Zhang Y (2022) Molecular characteristics, clinical significance, and cancer immune interactions of angiogenesis-associated genes in gastric cancer. Front Immunol 13:843077

    Article  CAS  Google Scholar 

  • Quail DF, Joyce JA (2013) Microenvironmental regulation of tumor progression and metastasis. Nat Med 19(11):1423–1437

    Article  CAS  Google Scholar 

  • Ransohoff JD, Wei Y, Khavari PA (2018) The functions and unique features of long intergenic non-coding RNA. Nat Rev Mol Cell Biol 19(3):143–157

    Article  CAS  Google Scholar 

  • Robinson NJ, Schiemann WP. Telomerase in Cancer: Function, Regulation, and Clinical Translation. Cancers. 2022;14(3).

  • Russo AE, Strong VE (2019) Gastric cancer etiology and management in Asia and the West. Annu Rev Med 70:353–367

    Article  CAS  Google Scholar 

  • Samstein RM, Lee CH, Shoushtari AN, Hellmann MD, Shen R, Janjigian YY et al (2019) Tumor mutational load predicts survival after immunotherapy across multiple cancer types. Nat Genet 51(2):202–206

    Article  CAS  Google Scholar 

  • Sasaki T, Kuniyasu H, Luo Y, Kitayoshi M, Tanabe E, Kato D et al (2014) AKT activation and telomerase reverse transcriptase expression are concurrently associated with prognosis of gastric cancer. Pathobiology 81(1):36–41

    Article  CAS  Google Scholar 

  • Schaefer CF, Anthony K, Krupa S, Buchoff J, Day M, Hannay T et al (2009) PID: the Pathway Interaction Database. Nucleic Acids Res 37(Database issue):674–679

    Article  Google Scholar 

  • Shao JC, Wu JF, Wang DB, Qin R, Zhang H (2003) Relationship between the expression of human telomerase reverse transcriptase gene and cell cycle regulators in gastric cancer and its significance. World J Gastroenterol 9(3):427–431

    Article  CAS  Google Scholar 

  • Sharma S, Chowdhury S. Emerging mechanisms of telomerase reactivation in cancer. Trends in cancer. 2022.

  • Shen D, Ding L, Lu Z, Wang R, Yu C, Wang H et al (2022) METTL14-mediated Lnc-LSG1 m6A modification inhibits clear cell renal cell carcinoma metastasis via regulating ESRP2 ubiquitination. Mol Therapy Nucleic Acids 27:547–561

    Article  CAS  Google Scholar 

  • Shi Y, Zhang Y, Zhang L, Ma JL, Zhou T, Li ZX et al (2019) Telomere length of circulating cell-free DNA and gastric cancer in a Chinese population at high-risk. Front Oncol 9:1434

    Article  Google Scholar 

  • Tang X, Wu X, Guo T, Jia F, Hu Y, Xing X et al (2022) Focal adhesion-related signatures predict the treatment efficacy of chemotherapy and prognosis in patients with gastric cancer. Front Oncol 12:808817

    Article  Google Scholar 

  • Wang F, Wei XL, Wang FH, Xu N, Shen L, Dai GH et al (2019) Safety, efficacy and tumor mutational burden as a biomarker of overall survival benefit in chemo-refractory gastric cancer treated with toripalimab, a PD-1 antibody in phase Ib/II clinical trial NCT02915432. Ann Oncol 30(9):1479–1486

    Article  CAS  Google Scholar 

  • Wang W, Pei Q, Wang L, Mu T, Feng H (2022) Construction of a prognostic signature of 10 autophagy-related lncRNAs in gastric cancer. Int J Gen Med 15:3699–3710

    Article  CAS  Google Scholar 

  • Wu Y, Li G, He D, Yang F, He G, He L et al (2016) Telomerase reverse transcriptase methylation predicts lymph node metastasis and prognosis in patients with gastric cancer. Onco Targets Ther 9:279–286

    Article  CAS  Google Scholar 

  • Wu L, Cai S, Deng Y, Zhang Z, Zhou X, Su Y et al (2021) PD-1/PD-L1 enhanced cisplatin resistance in gastric cancer through PI3K/AKT mediated P-gp expression. Int Immunopharmacol 94:107443

    Article  CAS  Google Scholar 

  • Ye J, Liu H, Xu ZL, Zheng L, Liu RY (2019) Identification of a multidimensional transcriptome prognostic signature for lung adenocarcinoma. J Clin Lab Anal 33(9):e22990

    Article  Google Scholar 

  • Yu G, Wang LG, Han Y, He QY (2012) clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS 16(5):284–287

    Article  CAS  Google Scholar 

  • Zhan WH, Ma JP, Peng JS, Gao JS, Cai SR, Wang JP et al (1999) Telomerase activity in gastric cancer and its clinical implications. World J Gastroenterol 5(4):316–319

    Article  Google Scholar 

  • Zhang C, Chen X, Li L, Zhou Y, Wang C, Hou S (2015) The association between telomere length and cancer prognosis: evidence from a meta-analysis. PLoS ONE 10(7):e0133174

    Article  Google Scholar 

  • Zhao Q, Cao L, Guan L, Bie L, Wang S, Xie B et al (2019) Immunotherapy for gastric cancer: dilemmas and prospect. Brief Funct Genomics 18(2):107–112

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We acknowledge the TCGA database for providing their

Funding

No funding was received.

Author information

Authors and Affiliations

  1. Department of Gastrointestinal and Anorectal Surgery, The Central Hospital of Yongzhou, No. 151, Xiaoshui West Road, Lingling District, Yongzhou, 425100, Hunan Province, China

    Jinggao Feng, Xiayu Tang, Liusong Song, Zhipeng Zhou, Yuan Jiang & Yao Huang

Authors
  1. Jinggao Feng
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Xiayu Tang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Liusong Song
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Zhipeng Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yuan Jiang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yao Huang
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

JF participated in the concept and design, data screening and analysis, and all authors for manuscript drafting platforms and contributors for uploading their meaningful datasets. Meanwhile, thanks to Ms. Danyan Zhuang for her support and companionship in writing and revising this article, love and touching always!

Corresponding author

Correspondence to Jinggao Feng.

Ethics declarations

Competing interests

The authors declare no competing interests.

Conflict of interest

No rights disclosure.

Ethical approval and consent to participate

As this work is a bioinformatics analysis, ethical approval is not required.

Consent for publication

All authors agree to publish.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 13 KB)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Feng, J., Tang, X., Song, L. et al. A telomerase regulation-related lncRNA signature predicts prognosis and immunotherapy response for gastric cancer. J Cancer Res Clin Oncol 149, 135–146 (2023). https://doi.org/10.1007/s00432-022-04456-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00432-022-04456-6

Keywords

Search

Navigation